These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 24715436)

  • 1. Cardiovascular magnetic resonance T2 mapping can detect myocardial edema in idiopathic dilated cardiomyopathy.
    Nishii T; Kono AK; Shigeru M; Takamine S; Fujiwara S; Kyotani K; Aoyama N; Sugimura K
    Int J Cardiovasc Imaging; 2014 Jun; 30 Suppl 1():65-72. PubMed ID: 24715436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular magnetic resonance tagging imaging correlates with myocardial dysfunction and T2 mapping in idiopathic dilated cardiomyopathy.
    Kono AK; Croisille P; Nishii T; Nishiyama K; Kyotani K; Shigeru M; Takamine S; Fujiwara S; Sugimura K
    Int J Cardiovasc Imaging; 2014 Dec; 30 Suppl 2():145-52. PubMed ID: 25156691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence of myocardial edema in patients with nonischemic dilated cardiomyopathy.
    Jeserich M; Föll D; Olschewski M; Kimmel S; Friedrich MG; Bode C; Geibel A
    Clin Cardiol; 2012 Jun; 35(6):371-6. PubMed ID: 22460822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T1 mapping in dilated cardiomyopathy with cardiac magnetic resonance: quantification of diffuse myocardial fibrosis and comparison with endomyocardial biopsy.
    aus dem Siepen F; Buss SJ; Messroghli D; Andre F; Lossnitzer D; Seitz S; Keller M; Schnabel PA; Giannitsis E; Korosoglou G; Katus HA; Steen H
    Eur Heart J Cardiovasc Imaging; 2015 Feb; 16(2):210-6. PubMed ID: 25246502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac MRI for clinical dilated cardiomyopathy: Improved diagnostic power via combined T1, T2, and ECV.
    Jia SQ; Lv SY; Jin YH; Zhao Y; Tian LP; Chang MM; Yan CL; Qi XL
    Radiography (Lond); 2024 May; 30(3):926-931. PubMed ID: 38657385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [T1 mapping and late gadolinium enhancement for the diagnosis of dilated cardiomyopathy].
    Cui Q; Yu J; Ge X; Gao G; Liu Y; Shen W
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Dec; 32(12):1506-1510. PubMed ID: 33541506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-contrast T1-mapping detects acute myocardial edema with high diagnostic accuracy: a comparison to T2-weighted cardiovascular magnetic resonance.
    Ferreira VM; Piechnik SK; Dall'Armellina E; Karamitsos TD; Francis JM; Choudhury RP; Friedrich MG; Robson MD; Neubauer S
    J Cardiovasc Magn Reson; 2012 Jun; 14(1):42. PubMed ID: 22720998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T1 and T2 mapping for early diagnosis of dilated non-ischaemic cardiomyopathy in middle-aged patients and differentiation from normal physiological adaptation.
    Mordi I; Carrick D; Bezerra H; Tzemos N
    Eur Heart J Cardiovasc Imaging; 2016 Jul; 17(7):797-803. PubMed ID: 26358692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of myocardial fibrosis and ventricular dyssynchrony on response to therapy in new-presentation idiopathic dilated cardiomyopathy: insights from cardiovascular magnetic resonance and echocardiography.
    Leong DP; Chakrabarty A; Shipp N; Molaee P; Madsen PL; Joerg L; Sullivan T; Worthley SG; De Pasquale CG; Sanders P; Selvanayagam JB
    Eur Heart J; 2012 Mar; 33(5):640-8. PubMed ID: 22048681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T2 mapping cardiovascular magnetic resonance identifies the presence of myocardial inflammation in patients with dilated cardiomyopathy as compared to endomyocardial biopsy.
    Spieker M; Katsianos E; Gastl M; Behm P; Horn P; Jacoby C; Schnackenburg B; Reinecke P; Kelm M; Westenfeld R; Bönner F
    Eur Heart J Cardiovasc Imaging; 2018 May; 19(5):574-582. PubMed ID: 29136120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fat deposition in dilated cardiomyopathy assessed by CMR.
    Lu M; Zhao S; Jiang S; Yin G; Wang C; Zhang Y; Liu Q; Cheng H; Ma N; Zhao T; Chen X; Huang J; Zou Y; Song L; He Z; An J; Renate J; Xue H; Shah S
    JACC Cardiovasc Imaging; 2013 Aug; 6(8):889-98. PubMed ID: 23850250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Importance of Myocardial T
    Amano Y; Omori Y; Ando C; Yanagisawa F; Suzuki Y; Tang X; Kobayashi H; Takagi R; Matsumoto N
    Magn Reson Med Sci; 2021 Jun; 20(2):139-151. PubMed ID: 32389929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variability and homogeneity of cardiovascular magnetic resonance myocardial T2-mapping in volunteers compared to patients with edema.
    Wassmuth R; Prothmann M; Utz W; Dieringer M; von Knobelsdorff-Brenkenhoff F; Greiser A; Schulz-Menger J
    J Cardiovasc Magn Reson; 2013 Mar; 15(1):27. PubMed ID: 23537111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of myocardial deformation with cardiac magnetic resonance strain imaging improves risk stratification in patients with dilated cardiomyopathy.
    Buss SJ; Breuninger K; Lehrke S; Voss A; Galuschky C; Lossnitzer D; Andre F; Ehlermann P; Franke J; Taeger T; Frankenstein L; Steen H; Meder B; Giannitsis E; Katus HA; Korosoglou G
    Eur Heart J Cardiovasc Imaging; 2015 Mar; 16(3):307-15. PubMed ID: 25246506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is cardiac and hepatic iron status assessed by MRI T2* associated with left ventricular function in patients with idiopathic cardiomyopathy?
    Kanzaki Y; Yuki M; Yamamura KI; Narumi Y; Ishizaka N
    Heart Vessels; 2016 Dec; 31(12):1950-1959. PubMed ID: 26897743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myocardial extracellular volume fraction measurements with MOLLI 5(3)3 by cardiovascular MRI for the discrimination of healthy volunteers from dilated and hypertrophic cardiomyopathy patients.
    Cui Y; Chen Y; Cao Y; Liu J; Song J; Zhang S; Kong X; Han P; Shi H
    Clin Radiol; 2019 Sep; 74(9):732.e9-732.e16. PubMed ID: 31122714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracellular volume fraction in dilated cardiomyopathy patients without obvious late gadolinium enhancement: comparison with healthy control subjects.
    Hong YJ; Park CH; Kim YJ; Hur J; Lee HJ; Hong SR; Suh YJ; Greiser A; Paek MY; Choi BW; Kim TH
    Int J Cardiovasc Imaging; 2015 Jun; 31 Suppl 1():115-22. PubMed ID: 25634119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurement of myocardium at risk with cardiovascular MR: comparison of techniques for edema imaging.
    McAlindon EJ; Pufulete M; Harris JM; Lawton CB; Moon JC; Manghat N; Hamilton MC; Weale PJ; Bucciarelli-Ducci C
    Radiology; 2015 Apr; 275(1):61-70. PubMed ID: 25333474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diffuse Myocardial Fibrosis and Inflammation in Rheumatoid Arthritis: Insights From CMR T1 Mapping.
    Ntusi NAB; Piechnik SK; Francis JM; Ferreira VM; Matthews PM; Robson MD; Wordsworth PB; Neubauer S; Karamitsos TD
    JACC Cardiovasc Imaging; 2015 May; 8(5):526-536. PubMed ID: 25890584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical feasibility study for detection of myocardial oedema by a cine SSFP sequence in comparison to a conventional T2-weighted sequence.
    Steen H; Voss F; André F; Neizel M; Schäufele T; Lehrke S; Lossnitzer D; Giannitsis E; Katus HA
    Clin Res Cardiol; 2012 Feb; 101(2):125-31. PubMed ID: 22038389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.